Geoffrey Chan is an expert in the field of Hematology. He graduated from Warren Alpert Medical School of Brown University. Doctor Geoffrey W. Chan, MD is also published. He has 5 publications published. The lastest publication: "Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase II international study.'
![]() |
Dr. Jeremey Levin, MD |
![]() |
Dr. Stephen D. Rubin, MD |
![]() |
Dr. Minal M. Dhamankar, MD
![]() |